Target intelligence / Profile preview

Arginine N-succinyltransferase (AST)

Target
AST
Molecular classification
Enzyme, Transferase, Acyltransferase
01

Overview

Arginine N-succinyltransferase is the primary enzyme in the arginine succinyltransferase (AST) pathway, a major catabolic route for L-arginine in bacteria such as Pseudomonas aeruginosa and Escherichia coli (UniProt P09050, P0A9M0). It catalyzes the transfer of a succinyl group from succinyl-CoA to the alpha-amino group of L-arginine, producing N2-succinyl-L-arginine (EC 2.3.1.109). This metabolic process allows the bacteria to utilize arginine as a source of carbon, nitrogen, and energy, which is vital for survival in diverse environments (PubMed: 10411748). In pathogens like P. aeruginosa, the AST pathway is involved in the regulation of virulence and adaptation to the host environment. Although there are currently no clinical drugs targeting this enzyme, it is considered a viable target for novel antibacterial strategies due to its absence in human metabolic pathways. Inhibiting this enzyme could potentially disrupt bacterial growth and reduce the fitness of the pathogen during infection.

Other names
Arginine succinyltransferaseL-arginine N2-succinyltransferaseSuccinyl-CoA:L-arginine N2-succinyltransferaseAruAAstA
02

Mechanism of action

Inhibition of the arginine succinyltransferase pathway to disrupt bacterial nitrogen utilization and growth.

03

Biological functions

Arginine catabolismNitrogen metabolismAmino acid metabolism
04

Disease associations

Infection
05

Safety considerations

Target selectivityBacterial resistance development
06

Biomarkers

N2-succinyl-L-arginine levels

Beyond the preview

Go deeper on Arginine N-succinyltransferase (AST).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arginine N-succinyltransferase (AST).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call